mRNA Vax Against COVID-19 Passes First Hurdle

(MedPage Today) -- Moderna's mRNA vaccine against SARS-CoV-2 produced an immune response in healthy adult volunteers and was mostly well-tolerated, interim findings from a phase I dose-escalation trial found.
Participants receiving the highest...